Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | IV |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C31H55N3O6 |
Molar mass | 565.796 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Enocitabine (INN, marketed under the brand name Sunrabin) is a nucleoside analog used as chemotherapy.
Sunrabin contains the emulsifier HCO-60, which can cause allergic reactions.
References
- Tatetsu H, Asou N, Nakamura M, et al. (July 2003). "". Rinsho Ketsueki (in Japanese). 44 (7): 471–3. PMID 12931567.
- (in Japanese) Sunrabin
This antineoplastic or immunomodulatory drug article is a stub. You can help Misplaced Pages by expanding it. |